Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-18

FDA Approved: TREPROSTINIL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application from Sandoz Inc for TREPROSTINIL, adding a water solution formulation of treprostinil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Treprostinil (treprostinil)

Snippet

SUPPL AP for TREPROSTINIL (TREPROSTINIL)